| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/17/2023 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 1.5k | $0.00 | $0 | | 02/17/2023 |
| 02/15/2022 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 10k | $0.00 | $0 | | 02/15/2022 |
| 03/01/2021 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 10k | $0.00 | $0 | | 03/01/2021 |
| 11/18/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 225k | $0.10 | $22.5k | | 11/18/2019 |
| 08/01/2019 | Phio Pharmaceuticals Corp. | RXII | Payment of Exercise | Common stock, $0.0001 par value | 1.8k | $0.40 | $705.7 | | 08/01/2019 |
| 02/28/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 152.4k | $0.38 | $57.9k | | 02/28/2019 |
| 02/15/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 22.3k | $0.36 | $8.1k | | 02/15/2019 |
| 02/01/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common Stock, $0.0001 par value | 21.5k | $0.38 | $8.1k | | 02/01/2019 |
| 01/18/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 23.7k | $0.34 | $8.1k | | 01/18/2019 |
| 01/04/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 23.1k | $0.35 | $8.1k | | 01/04/2019 |
| 12/21/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 27.4k | $0.30 | $8.1k | | 12/21/2018 |
| 12/07/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 21.9k | $0.37 | $8.1k | | 12/07/2018 |
| 11/23/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 25.9k | $0.31 | $8.1k | | 11/23/2018 |
| 11/09/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 18.7k | $0.43 | $8.1k | | 11/09/2018 |
| 10/26/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 18.5k | $0.44 | $8.1k | | 10/26/2018 |
| 10/12/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 17.2k | $0.47 | $8.1k | | 10/12/2018 |
| 09/28/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock, $0.0001 par value | 73.6k | $1.17 | $86.1k | | 09/28/2018 |
| 08/01/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common Stock | 21k | $0.00 | $0 | | 08/01/2018 |
| 08/01/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Stock option (right to buy) | 21k | $1.79 | $37.6k | | 08/01/2018 |
| 10/02/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 2.7k | $0.44 | $1.2k | | 10/02/2017 |
| 10/02/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 200 | $0.46 | $92 | | 10/02/2017 |
| 10/02/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 7.1k | $0.45 | $3.2k | | 10/02/2017 |
| 08/24/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 4.9k | $0.55 | $2.7k | | 08/24/2017 |
| 08/24/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 4.4k | $0.55 | $2.4k | | 08/24/2017 |
| 08/24/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 739 | $0.56 | $413.8 | | 08/24/2017 |
| 06/22/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 5k | $0.63 | $3.2k | | 06/22/2017 |
| 06/22/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 5k | $0.62 | $3.1k | | 06/22/2017 |
| 04/26/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 10k | $0.65 | $6.5k | | 04/26/2017 |
| 03/17/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 9.3k | $0.77 | $7.2k | | 03/17/2017 |
| 03/17/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 15 | $0.77 | $11.5 | | 03/17/2017 |
| 03/17/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 665 | $0.77 | $508.8 | | 03/17/2017 |
| 02/17/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 6.9k | $0.69 | $4.8k | | 02/17/2017 |
| 02/17/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 2.9k | $0.70 | $2k | | 02/17/2017 |
| 02/17/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 200 | $0.69 | $138.3 | | 02/17/2017 |
| 02/08/2017 | Phio Pharmaceuticals Corp. | RXII | Purchase | Common stock, $0.0001 par value | 10k | $0.69 | $6.8k | | 02/08/2017 |
|